Welcome to our dedicated page for AMBIPAR EMERGENCY RESPONSE news (Ticker: AMBI), a resource for investors and traders seeking the latest updates and insights on AMBIPAR EMERGENCY RESPONSE stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AMBIPAR EMERGENCY RESPONSE's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AMBIPAR EMERGENCY RESPONSE's position in the market.
Ambipar Emergency Response (NYSE: AMBI) has announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2024, with the U.S. Securities and Exchange Commission (SEC) on June 23, 2025.
The 2024 Annual Report and audited financial statements are accessible through both the SEC's website and the Company's investor relations website. Shareholders and warrant-holders can request hard copies of the audited financial statements free of charge via email.
FAQ
What is the current stock price of AMBIPAR EMERGENCY RESPONSE (AMBI)?
What is the market cap of AMBIPAR EMERGENCY RESPONSE (AMBI)?
